Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.
McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYM, Cook G, Parrish C, Al-Kaisi F, Pratt G, Shafeek S, Jenkins S, Memon D, Bygrave C, Papanikolaou X, Maisel T, Hassan S, Moosai S, Chander G, Rakesh P, Kishore B, Karim F, Talbot G, Wandroo F, Yong K, Popat R.
McMillan A, et al. Among authors: basu s.
Br J Haematol. 2023 May;201(4):682-689. doi: 10.1111/bjh.18703. Epub 2023 Feb 23.
Br J Haematol. 2023.
PMID: 36822820